Healthy Extracts has reported strong revenue growth and record financial results in 2025, expanded its product portfolio through acquisitions and partnerships, and launched new nutraceutical products targeting specific health needs.

• Healthy Extracts reported 2025 net revenue of $4.5 million, a 45% increase over prior periods, marking a record high for the company [N1].
• The company completed the acquisition of Gummy USA LLC, enhancing its precision-dosed gummy supplement capabilities and manufacturing scale [N7].
• Healthy Extracts formed a strategic manufacturing and commercial partnership with Gelteq to expand gel-based nutrition technologies in North America [N3].
• Q3 2025 revenue increased by 23%, continuing the company's trend of strong quarterly growth [N4].
• The company launched new products including revolutionary hydration and sugar metabolism gel-packs and the STAT10 formulation for statin users [N3][N8].
• Healthy Extracts CEO highlighted accelerating growth through the Gummy USA merger and technology advancements in a Money Channel interview [N8].

Healthy Extracts has demonstrated strong revenue growth with a 45% increase in 2025 net revenue to $4.5 million, driven by product innovation and strategic acquisitions such as Gummy USA. Expansion of gel-based nutrition technologies through partnerships like Gelteq enhances its product offerings and manufacturing scale. The company's multi-channel marketing approach, including Amazon and retail presence, supports broader market access. Continued product development and clinical validation may strengthen brand credibility and customer loyalty.

Despite revenue growth, Healthy Extracts reported a net loss of $881,119 in 2025 and liquidity ratios below 1.0, indicating potential financial constraints. The nutraceutical market is competitive and subject to regulatory scrutiny, which may impact product acceptance and sales. Integration risks exist related to acquisitions and management changes. Dependence on a limited product portfolio and key partnerships may pose risks if market conditions or consumer preferences shift unfavorably.

Healthy Extracts' moat is built on proprietary nutraceutical formulations, including gel-based delivery technologies and precision-dosed gummies, supported by strategic partnerships and acquisitions that enhance manufacturing and commercial capabilities. The company's focus on innovation, clinical validation, and multi-channel distribution contributes to differentiation in the competitive health supplement market. Brand recognition through product launches and marketing initiatives further supports its competitive position.

• Profitability and Liquidity Risks: The company reported a net loss in 2025 and has a current ratio below 1.0, indicating potential challenges in meeting short-term obligations and achieving sustained profitability.
• Integration and Management Risks: Recent acquisitions and leadership changes may present integration challenges and execution risks that could affect operational stability.
• Market and Regulatory Risks: The nutraceutical industry faces competitive pressures and regulatory oversight that could impact product development, marketing, and sales.

• Healthy Extracts Inc. operates in the nutraceutical and health supplement sector, focusing on innovative nutritional products including gel-based nutrition technologies and precision-dosed gummy supplements.
• The company reported record net revenue of $4.5 million for the fiscal year 2025, representing a 45% increase over prior periods, as disclosed in its 10-K filing for the year ended December 31, 2025, and multiple press releases [N1][S1].
• Healthy Extracts acquired Gummy USA LLC in 2025, a precision-dosed nutraceutical gummy technology innovator and manufacturer, integrating it as a wholly-owned subsidiary, which supports its product expansion and manufacturing capabilities [N7][S2].
• The company has formed a strategic manufacturing and commercial partnership with Gelteq to expand gel-based nutrition technologies in North America [N3].
• Recent quarterly results show continued revenue growth, including a 23% increase in Q3 2025 revenue [N4][S2].
• The company has launched new products such as revolutionary hydration and sugar metabolism gel-packs, and the STAT10 formulation targeting statin users, indicating ongoing product innovation [N3][N8].
• Healthy Extracts has engaged in marketing and distribution initiatives including Amazon Prime Day product launches and retail marketplace entries, enhancing its market presence [N8].
• Financial snapshot as of December 31, 2025, shows current assets of approximately $1.33 million and current liabilities of approximately $1.69 million, resulting in a current ratio of 0.79 and a cash ratio of 0.07, indicating liquidity below 1.0 [S1].
• The company reported a net loss of approximately $881,119 for the fiscal year 2025 despite revenue growth, reflecting ongoing profitability challenges [S1].
• Management changes occurred in 2025 with Donald Swanson appointed as Chairman, CEO, and board member following the Gummy USA acquisition, indicating leadership continuity and strategic focus [S2].